Research graph
References from Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability, and Clinical Outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
10.1016/s0140-6736(16)32409-6 · 2017 · External reference
Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT
10.1016/j.hpb.2016.11.001 · 2017 · External reference
Repeated pancreatectomy for isolated local recurrence in the remnant pancreas following radical pancreatectomy for pancreatic ductal adenocarcinoma: a pooled analysis
10.3390/jcm9123945 · 2020 · External reference
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
10.1016/s0140-6736(23)01366-1 · 2023 · External reference
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
10.1056/nejmoa1304369 · 2013 · External reference
A phase II study of modified FOLFIRINOX for chemotherapy-naive patients with metastatic pancreatic cancer
10.1007/s00280-018-3577-9 · 2018 · External reference
Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma
10.21037/jgo.2017.03.04 · 2017 · External reference
Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas.
10.1186/1748-717x-7-74 · 2012 · External reference
Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer
10.7150/jca.13295 · 2016 · External reference
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions
2013 · External reference
New possibilities and potential benefits for local control in locally recurrent pancreatic cancer
2013 · External reference
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
10.1200/jco.2008.17.7188 · 2009 · External reference
Alliance A021501: preoperative mFOLFIR- INOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas
10.1200/jco.2021.39.3_suppl.377 · 2021 · External reference
NAPOLI-3: a randomized, open-label phase 3 study of liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naıve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
10.1200/jco.2023.41.4_suppl.lba661 · 2023 · External reference
Re-irradiation with stereotactic body radiotherapy for in-field recurrence of pancreatic cancer after prior stereotactic body radiotherapy: analysis of 24 consecutive cases
10.3389/fonc.2021.729490 · 2021 · External reference
Efficacy and safety of reirradiation with stereotactic body radiation therapy for locally recurrent pancreatic adenocarcinoma
10.1016/j.clon.2021.12.014 · 2022 · External reference
Stereotactic body radiation therapy (SBRT) reirradiation after prior SBRT for pancreas cancer–outcomes and toxicity
10.1016/j.ijrobp.2018.07.413 · 2018 · External reference
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
10.1016/j.ijrobp.2003.11.004 · 2004 · External reference
